Cambridge University Health Partners welcomes ARIA to Cambridge

Cambridge x ARIA event coming up next week 2nd June! Advanced Research + Invention Agency (ARIA) are beginning to recruit the next cohort of Programme Directors and will be in Cambridge to share how they operate and what they look for in ambitious ideas and people - from individuals and startups to industry and academia. You should attend the event to: 🔹Explore funding opportunities 🔹Explore collaborations 🔹Explore leadership opportunities

Want an insight into how the Advanced Research + Invention Agency (ARIA) supports breakthrough research with the potential for major societal and economic impact? This session is for you 🫵

Amazing work with my PhD advisor Thomas Sakmar that quantifies the link between academic research and patient impact! As a scientist-turned-consultant I love a good framework: Cure Innovation Index ranks universities according to 1) research capabilities, 2)entrepreneurial readiness, and 3)market translation. One KTA for biotech: traditional sources of innovation like big-name academic centers are not necessarily the best places for translatable assets. Cure’s index now provides a data-driven way to identify institutions that produce licensable, de-risked science, and will be a valuable tool for Biotech, larger biotech and pharma, and VC.

The Cure. Innovation Index - analysing the systems that make translation of great science repeatable and providing a framework for organisations committed to turning discovery into impact. While it is a measure of US academic institutions the index provides valuable insights for Australian organisations seeking to drive progress in translating scientific discoveries into real healthcare solutions. A fantastic resource. Congratulations Seema Kumar and the team at Cure. #CureInnovationIndex26

Recently, I applied for admission to the SH1P x National Student Research Institution (NSRI) Ultra Competitive Research & Investing Cohorts, a worldwide initiative that pairs driven individuals with various opportunities related to conducting research, innovating, and making investments. What makes the initiative unique is the program's focus not only on fostering the development of the scientific and analytical skills needed to conduct publishable research but also on helping students understand how venture capitalists evaluate ideas, technology, and their long-term implications. The network offered by the initiative is massive: - More than 11,000 active researchers - Participants from more than 100 different countries - Mentorship from researchers and experts from some of the world's top schools - Connections to investors working with organizations like Anthropic, Antler, Breakthrough Ventures, and Afore Capital Given my interest in medicine, especially neuroscience, clinical research, and AI integration in the field, this kind of opportunity seems very valuable to me from the perspectives of research skill building and gaining cross disciplinary knowledge. To all those interested in any of the above fields, I would recommend considering this initiative. https://lnkd.in/decQE_HD #Medicine #MedicalStudent #Research #ClinicalResearch #MedicalResearch #Neuroscience #Neurology #ArtificialIntelligence #AIinMedicine #Healthcare #Innovation #Biotechnology #Investing #ScientificResearch #GlobalHealth #FutureOfMedicine #StudentResearch #UndergraduateResearch #ResearchOpportunities #AcademicMedicine #Science #Technology #Startups #Entrepreneurship #FutureHealthcare #MedTech #DigitalHealth #MedicalInnovation #Leadership #Networking #CareerDevelopment #Researchers #InternationalStudents #LinkedIn #Education #STEM

Congratulations to Carter Palmer on being recognized as the 2026 Student/Alumni Innovator of the Year for the Chancellor’s Innovation Awards. What began with the heartbreak of watching a loved one lose memory and identity to neurodegeneration has become a bold scientific effort to change the future of brain health. Carter co-founded Third Element Bio to take on one of medicine’s most difficult frontiers: how to preserve cognition, independence, and quality of life as the brain ages. By combining advanced human brain cell analysis with AI-driven drug design, the company is developing RNA therapeutics aimed not at managing symptoms — but at rewiring the cellular aging programs that drive diseases like Alzheimer’s, Parkinson’s and ALS. As a UC San Diego alumnus, Carter has leveraged the university’s innovation ecosystem — including StartR, the Institute for the Global Entrepreneur’s MedTech Accelerator, and the Rady School of Management venture fellow programs — to help move this vision from concept to company. Congratulations as well to co-founders Christine Liu and Tony Ngo for building a company with the potential to redefine how we treat neurodegenerative disease and extend healthy cognitive lifespan for millions. Some startups build products. Others build a different future. Carter and Third Element Bio are doing the latter. #Neurotech #Biotech #Alzheimers #UCSanDiego #UCSDAlumni

If you’re in NYC next week and interested in innovation, entrepreneurship, healthcare, AI, or engineering, we hope you’ll join us for an afternoon hosted by the Hellenic Institute of Advanced Studies, Columbia Engineering, and the Columbia Global Center Athens We are excited to hear from Professor Elisa Konofagou, whose groundbreaking work in biomedical ultrasound and noninvasive therapies has positioned her as a leader in healthcare innovation and translational research. Her perspective on bridging engineering, medicine, and entrepreneurship promises to be a highlight of the program. And while the speakers are outstanding, the real stars of the show will be the talented young Greek and Turkish entrepreneurs presenting new ideas at the intersection of technology, healthcare and engineering! We hope to see you there! https://luma.com/1kqbe4wy #NationalTechnicalUniversityofAthens #KocUniversity #Innovation #Entrepreneurship #BiomedicalEngineering #HealthTech #ColumbiaUniversity

The 2026 MIT Health Science & Technology Forum brought together an extraordinary community to explore where healthcare is headed next - and what it will take to get there. This year’s program highlighted the convergence of biology, engineering, and computation across early disease detection, brain science, microbial therapeutics, targeted drug delivery, and AI-enabled health technologies - offering a powerful view into the future of precision health. Thank you to our speakers for sharing both groundbreaking research and a clear commitment to real-world impact. María José Durán González opened the program by illustrating how synthetic biology and neuromorphic approaches are expanding what’s possible in engineered cellular systems. Tami Lieberman provided critical insight into the human microbiome, advancing our understanding of microbial therapeutics and the challenge of durable engraftment. Paul Liang showed how multisensory AI is reshaping clinical reasoning and unlocking new capabilities across complex health data. In the second half of the program, Ana Jaklenec demonstrated how innovative materials and delivery platforms can make vaccines more scalable and accessible globally, while Guoping Feng highlighted the power of AI and collaborative data ecosystems to accelerate breakthroughs in rare and complex brain disorders. Across all of these perspectives, the throughline was clear: meaningful progress in healthcare depends on deep cross-disciplinary collaboration and a shared focus on translation. We’re deeply grateful to our #MIT faculty, #ILP members, #StartupExchange companies, and attendees for making this forum so engaging and impactful - and we look forward to continuing this work together. MIT Industrial Liaison Program MIT Startup Exchange Mikihiko Kato Peter Lohse Catarina Machado Madeira

I want to share with you the research being performed at Syracuse University Stuttering Research Laboratory. The Hart Speech Foundation has been providing funding to Syracuse University for several years in support of their research and clinical trials.

A new Penn State Clinical and Translational Science Institute publication highlights a major research communication gap: most study participants never receive results. The study shares community-informed strategies for helping researchers better communicate findings to the public: https://ow.ly/zpcZ50Z1GFZ